Raily Aesthetic Medicine International Holdings Ltd. has announced a discloseable transaction involving the subscription of shares in a target company. On January 6, 2026, after trading hours, Miusee Beauty, the investors, the shareholders, and the target company entered into a subscription agreement. Under the agreement, Raily Aesthetic Medicine, through its group companies, will subscribe for shares in the target company, resulting in a minority equity interest. The transaction constitutes a discloseable transaction under Chapter 14 of the Hong Kong Listing Rules, as the highest applicable percentage ratio exceeds 5% but is less than 25%. The deal is subject to reporting and announcement requirements but does not require shareholders' approval. The principal activities of Raily Aesthetic Medicine include aesthetic surgery, minimally-invasive aesthetic services, dermatology, and related consulting and equipment sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raily Aesthetic Medicine International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260106-11982293), on January 06, 2026, and is solely responsible for the information contained therein.